187 results on '"Kanetaka K"'
Search Results
2. Outcome of the Liver Resection, Liver Transplantation, Local Therapy for HCC Less Than 3cm, 3 Nodules.: Abstract# A377
- Author
-
Hidaka, M., Takatsuki, M., Soyama, A., Kinoshita, A., Natsuda, K., Kugiyama, T., Kitasato, A., Adachi, T., Baimakhanov, Z., Fujita, F., Kanetaka, K., Kuroki, T., and Eguchi, S.
- Published
- 2014
3. The Efficacy of Software to Help Patients Understand Drug for Adjuvant Treatment for Breast Cancer: A Pilot Randomized Controlled Trial
- Author
-
Kuba, S., Yamanouchi, K., Morita, M., Sakimura, C., Inamasu, E., Hatachi, T., Otsubo, R., Matsumoto, M., Yano, H., Miyamoto, J., Shuntaro Sato, Nakagawa, H., Kanetaka, K., Takatsuki, M., Nagayasu, T., and Eguchi, S.
- Subjects
Adult ,Health Knowledge, Attitudes, Practice ,ChemoCalc ,Breast Neoplasms ,Pilot Projects ,Middle Aged ,Drug Costs ,breast cancer ,Chemotherapy, Adjuvant ,Surveys and Questionnaires ,Humans ,Female ,Prospective Studies ,Software ,Aged - Abstract
We assessed the usefulness of ChemoCalc, a software package for calculating drug costs, in helping patients understand these costs. We randomly assigned, in a 1 : 1 ratio, 20 women who had undergone surgery for early breast cancer to a group that discussed adjuvant treatment with their physicians using the ChemoCalc software (ChemoCalc group) or a group that discussed adjuvant treatment without ChemoCalc (Usual Explanation group). The participants completed a five-grade evaluation questionnaire after these discussions. The primary endpoint was the intergroup comparison of the questionnaire scores regarding participants’ understanding of their treatment-associated drug costs. Median age was not significantly different between the ChemoCalc group and Usual Explanation group (57 vs. 50, respectively; p=0.27). Patients in the ChemoCalc group had a significantly higher perceived level of understanding of the drug cost than those in the Usual Explanation group (5 [4-5] vs. 2.5 [1-5], respectively; p=0.002). Scores related to the patients’ perception that understanding drug costs is an important part of breast cancer treatment were also higher in the ChemoCalc group than the Usual Explanation group (5 [2-5] vs. 3 [1-5], respectively; p=0.049). ChemoCalc was found to be useful for understanding drug costs.
- Published
- 2020
4. The elucidation of interaction between autonomic nervous system, immune system and pancreatic cancer
- Author
-
Ikeda, T., primary, Adachi, T., additional, Ono, S., additional, Tanaka, T., additional, Matsumura, N., additional, Hara, T., additional, Hidaka, M., additional, Kanetaka, K., additional, and Eguchi, S., additional
- Published
- 2021
- Full Text
- View/download PDF
5. Randomized phase II clinical trial of NY-ESO-1 protein vaccine combined with cholesteryl pullulan (CHP-NY-ESO-1) in resected esophageal cancer patients
- Author
-
Kageyama, S., primary, Nagata, Y., additional, Ishikawa, T., additional, Abe, T., additional, Murakami, M., additional, Kojima, T., additional, Taniguchi, K., additional, Shimada, H., additional, Hirano, S., additional, Ueda, S., additional, Kanetaka, K., additional, Wada, H., additional, Yamaue, H., additional, Sato, E., additional, Miyahara, Y., additional, Goshima, N., additional, Ikeda, H., additional, Yamada, T., additional, Osako, M., additional, and Shiku, H., additional
- Published
- 2019
- Full Text
- View/download PDF
6. Real time cholangiography using indocyanine green near-infrared fluorescence imaging in living donor hepatectomy
- Author
-
Ono, S., primary, Soyama, A., additional, Adachi, T., additional, Hidaka, M., additional, Hara, T., additional, Matsushima, H., additional, Kanetaka, K., additional, Takatsuki, M., additional, and Eguchi, S., additional
- Published
- 2018
- Full Text
- View/download PDF
7. S-1 and CPT-11 plus ramucirumab (IRIS+Rmab) as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: A multicenter phase II study in Japan (N-DOCC-F-C-1701)
- Author
-
Kobayashi, K., primary, Morita, M., additional, Ito, S., additional, Inoue, Y., additional, Yamaguchi, I., additional, Kosaka, T., additional, Kuba, S., additional, Sakimura, C., additional, Soyama, A., additional, Adachi, T., additional, Ohno, S., additional, Kobayashi, S., additional, Hara, T., additional, Hidaka, M., additional, Hayashida, N., additional, Yamanouchi, K., additional, Kanetaka, K., additional, Takatsuki, M., additional, and Eguchi, S., additional
- Published
- 2017
- Full Text
- View/download PDF
8. 1214P - Randomized phase II clinical trial of NY-ESO-1 protein vaccine combined with cholesteryl pullulan (CHP-NY-ESO-1) in resected esophageal cancer patients
- Author
-
Kageyama, S., Nagata, Y., Ishikawa, T., Abe, T., Murakami, M., Kojima, T., Taniguchi, K., Shimada, H., Hirano, S., Ueda, S., Kanetaka, K., Wada, H., Yamaue, H., Sato, E., Miyahara, Y., Goshima, N., Ikeda, H., Yamada, T., Osako, M., and Shiku, H.
- Published
- 2019
- Full Text
- View/download PDF
9. 192TiP - S-1 and CPT-11 plus ramucirumab (IRIS+Rmab) as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: A multicenter phase II study in Japan (N-DOCC-F-C-1701)
- Author
-
Kobayashi, K., Morita, M., Ito, S., Inoue, Y., Yamaguchi, I., Kosaka, T., Kuba, S., Sakimura, C., Soyama, A., Adachi, T., Ohno, S., Kobayashi, S., Hara, T., Hidaka, M., Hayashida, N., Yamanouchi, K., Kanetaka, K., Takatsuki, M., and Eguchi, S.
- Published
- 2017
- Full Text
- View/download PDF
10. Total Versus Hemithyroidectomy for Well Differentiated Thyroid Cancer
- Author
-
Kuba, S., primary, Yamanouchi, K., additional, Sakimura, C., additional, Kawakami, F., additional, Minami, S., additional, Fujita, F., additional, Takatsuki, M., additional, Kobayashi, K., additional, Kanetaka, K., additional, Kuroki, T., additional, and Eguchi, S., additional
- Published
- 2014
- Full Text
- View/download PDF
11. Outcome of the Liver Resection, Liver Transplantation, Local Therapy for HCC Less Than 3cm, 3 Nodules.
- Author
-
Hidaka, M., primary, Takatsuki, M., additional, Soyama, A., additional, Kinoshita, A., additional, Natsuda, K., additional, Kugiyama, T., additional, Kitasato, A., additional, Adachi, T., additional, Baimakhanov, Z., additional, Fujita, F., additional, Kanetaka, K., additional, Kuroki, T., additional, and Eguchi, S., additional
- Published
- 2014
- Full Text
- View/download PDF
12. Tissue-Engineered Myoblast Cell Sheets or the Treatment of Enteral Defects in a Rat Model
- Author
-
Tanaka, S., primary, Kanetaka, K., additional, Ito, S., additional, Yoneda, A., additional, Torashima, Y., additional, Fujita, F., additional, Takatsuki, M., additional, Kuroki, T., additional, and Eguchi, S., additional
- Published
- 2014
- Full Text
- View/download PDF
13. Prognostic Significance of CD44 Expression in Patients with Advanced T3/4 Gastric Adenocarcinoma
- Author
-
Kanetaka, K., primary
- Published
- 2012
- Full Text
- View/download PDF
14. 1034P - Total Versus Hemithyroidectomy for Well Differentiated Thyroid Cancer
- Author
-
Kuba, S., Yamanouchi, K., Sakimura, C., Kawakami, F., Minami, S., Fujita, F., Takatsuki, M., Kobayashi, K., Kanetaka, K., Kuroki, T., and Eguchi, S.
- Published
- 2014
- Full Text
- View/download PDF
15. Serum lipoprotein pattern in liver diseases, with special references to a differential diagnosis of cholestatic jaundice
- Author
-
Naito, C., Yamanaka, M., Endo, Y., Kanetaka, K., Oda, T., and Yoshitoshi, Y.
- Published
- 1971
- Full Text
- View/download PDF
16. Overexpression of tetraspanin CO-029 in hepatocellular carcinoma
- Author
-
Kanetaka, K., Sakamoto, M., Yamamoto, Y., Yamasaki, S., Lanza, F., Kanematsu, T., and Hirohashi, S.
- Published
- 2001
- Full Text
- View/download PDF
17. Positivity for cancer stem cell markers, cd44 and cd133, is a useful biomarker for predicting the outcomes of patients with advanced gastric cancer
- Author
-
Kanetaka, K., Takatsuki, M., Kuroki, T., Hayashi, T., Junya Fukuoka, and Eguchi, S.
18. Discordance of hormone receptor, human epidermal growth factor receptor-2, and Ki-67 between primary breast cancer and synchronous axillary lymph node metastasis
- Author
-
Kinoe, H., Yamanouchi, K., Kuba, S., Morita, M., Sakimura, C., Kanetaka, K., Takatsuki, M., Abe, K., Yano, H., Megumi Matsumoto, Otsubo, R., Hayashida, N., Nagayasu, T., and Eguchi, S.
19. Ulcerative colitis complicating pneumomediastinum, subcutaneous emphysema and pneumothorax.
- Author
-
Setake M, Tomiyama R, Kuda T, Maeshiro K, and Hokama A
- Abstract
A 17-year-old man with ulcerative colitis (UC) presented to our hospital with neck pain and fever after vomiting. On examination, a snowflake sensation was noted in the neck. A chest radiograph showed extensive subcutaneous emphysema in the chest. CT scans showed extensive subcutaneous emphysema in the neck, shoulders and axilla, as well as pneumomediastinum and pneumothorax. A diagnosis of pneumomediastinum with exacerbation of UC was made, and he was fasted and treated with antibiotics. Intensive granulocyte and monocyte adsorption apheresis (GMA) was started for exacerbation of UC. His symptoms and the radiological findings of pneumomediastinum improved. He remained in remission on azathioprine. UC is a chronic inflammatory bowel disease (IBD) associated with extraintestinal manifestations (EIM). Very few cases have been complicated by pneumomediastinum. The increase in alveolar pressure due to vomiting and systemic inflammation-related pleural or esophageal damage may cause pneumomediastinum in this case. Prevention of progression to mediastinitis and treatment of exacerbated UC are contradictory. GMA was successful because it was not an immunosuppressive therapy. Our case highlights that rare EIM may complicate exacerbation of UC.
- Published
- 2024
- Full Text
- View/download PDF
20. Multicenter retrospective analysis of complications and risk factors in endoscopic resection for esophageal cancer across Japan.
- Author
-
Ishihara R, Oyama T, Takeuchi M, Hirasawa D, Kanetaka K, Uesato M, Tsuji Y, Matsuura N, Abe S, Kadota T, Yoshio T, Tanaka T, Urabe Y, Suzuki Y, and Muto M
- Subjects
- Humans, Japan epidemiology, Retrospective Studies, Male, Female, Aged, Risk Factors, Middle Aged, Aged, 80 and over, Incidence, Pneumonia epidemiology, Pneumonia etiology, Esophagoscopy adverse effects, Esophagoscopy methods, Esophageal Perforation epidemiology, Esophageal Perforation etiology, Esophageal Neoplasms surgery, Endoscopic Mucosal Resection adverse effects, Endoscopic Mucosal Resection methods, Postoperative Complications epidemiology, Postoperative Complications etiology
- Abstract
Background: Endoscopic resection (ER) is a minimally invasive treatment for esophageal cancer that sometimes causes complications. To understand the real-world incidence and risk factors for these complications, a nationwide survey was conducted across Japan., Methods: This retrospective multicenter study included patients who underwent ER for esophageal cancer from April 2017 to March 2018 (2017 complication analysis) and April 2021 to March 2022 (2021 complication analysis). The study assessed the complication rates and conducted risk factor analyses for endoscopic submucosal dissection (ESD) using data for these patients, with exclusions based on specific criteria to ensure data accuracy., Results: In the 2021 complication analysis, there were two mortalities highly likely attributable (0.03%) to ER and one mortality possibly attributable (0.01%) to ER. Intraoperative perforation, delayed bleeding, and pneumonia occurred in 137 cases (1.8%), 44 cases (0.6%), and 130 cases (1.7%), respectively. In the multivariate analysis for complications after ESD, low ER volume of the facility was an independent risk factor for perforation, while lesion location in the cervical or upper thoracic esophagus was an independent factor for reduced risk of perforation. Age ≥ 80 years was a risk factor for pneumonia, while use of traction techniques was a factor for reduced risk of pneumonia. Lesions located in the middle thoracic esophagus had a lower risk of stricture, and the risk of stricture increased as the circumferential extent of the lesion increased., Conclusions: This large-scale study provided detailed insights into the complications associated with esophageal ER and identified significant risk factors., (© 2024. The Author(s) under exclusive licence to The Japan Esophageal Society.)
- Published
- 2024
- Full Text
- View/download PDF
21. A prospective randomized controlled study evaluating efficacy of Daikenchuto in the treatment of postoperative abdominal pain and bloating following hepatectomy.
- Author
-
Soyama A, Hidaka M, Hara T, Matsushima H, Nagakawa K, Migita K, Kawaguchi Y, Fukumoto M, Imamura H, Yamashita M, Adachi T, Kanetaka K, and Eguchi S
- Abstract
Background: The aim of this study was to evaluate the effectiveness and safety of TJ-100 TSUMURA Daikenchuto (DKT) Extract Granules in preventing post-hepatectomy digestive symptoms and the effects on small intestinal mucosal atrophy., Methods: Eligible patients were randomly assigned to the DKT therapy and usual care groups in a 1:1 ratio. The DKT therapy group was administered DKT for 14 days after surgery or until the day of discharge if the patient left the hospital before 14 days, and the usual care group did not receive DKT. We used the numeric rating scale to measure abdominal pain and bloating after surgery and compared the results between the two groups to determine the efficiency of DKT. We also evaluated postoperative small intestinal mucosal atrophy using diamine oxidase (DAO) and glucagon-like peptide-2 (GLP-2) activities in the serum, and postoperative complications., Results: No adverse effects were observed in the DKT group. No significant difference was observed in the area under the curve for postoperative abdominal pain or bloating throughout the study period. No differences were observed in DAO2, GLP2, and other nutrition assessment indicators. Four postoperative infections were observed in three patients (two with intra-abdominal surgical site infections [SSIs] and two with pneumonia). All cases of infection occurred in the control group., Conclusions: Although DKT did not significantly improve postoperative symptoms, such as abdominal pain or bloating, it is widely used in Japan to improve bowel movement and is safely prescribed for patients undergoing hepatectomy with a tendency toward less postoperative infection., Competing Interests: Declaration of competing interest The authors declare that they have no conflicts of interest., (Copyright © 2024 Asian Surgical Association and Taiwan Society of Coloproctology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
22. Chemotherapy effects on bone mineral density and microstructure in women with breast cancer.
- Author
-
Kuba S, Niimi R, Chiba K, Matsumoto M, Hara Y, Fukushima A, Tanaka A, Akashi M, Morita M, Inamasu E, Otsubo R, Kanetaka K, Osaki M, Matsumoto K, and Eguchi S
- Subjects
- Humans, Female, Middle Aged, Absorptiometry, Photon, Prospective Studies, Tomography, X-Ray Computed, Tartrate-Resistant Acid Phosphatase metabolism, Tartrate-Resistant Acid Phosphatase blood, Procollagen blood, Peptide Fragments blood, Bone Density drug effects, Breast Neoplasms drug therapy, Breast Neoplasms pathology
- Abstract
Introduction: Chemotherapy involves the administration of steroids to prevent nausea and vomiting; however, its effect on bone microstructure remains unknown. This study aimed to evaluate the changes in bone mineral density (BMD) and bone microstructure associated with chemotherapy using high-resolution peripheral quantitative computed tomography (HR-pQCT) in women with early breast cancer., Materials and Methods: This prospective single-arm observational study included non-osteoporotic, postmenopausal women with breast cancer. The patients underwent dual-energy X-ray absorptiometry (DXA), HR-pQCT, and tartrate-resistant acid phosphatase-5b (TRACP-5b) or procollagen type-I N-terminal propeptide (P1NP) measurements at baseline, end of chemotherapy, and 6 months after chemotherapy. The primary endpoint was the change in total volumetric BMD at the distal tibia and radius., Results: Eighteen women were included in the study (median age: 57 years; range: 55-62 years). At 6 months after chemotherapy, HR-pQCT indicated a significant decrease in total volumetric BMD (median: distal tibia -4.5%, p < 0.01; distal radius -2.3%, p < 0.01), cortical volumetric BMD (-1.9%, p < 0.01; -0.8%, p = 0.07, respectively), and trabecular volumetric BMD (-1.1%, p = 0.09; -3.0%, p < 0.01, respectively). The DXA BMD also showed a significant decrease in the lumbar spine (median: -4.5%, p < 0.01), total hip (-5.5%, p < 0.01), and femoral neck (-4.2%, p < 0.01). TRACP-5b and P1NP levels were significantly increased at the end of chemotherapy compared to baseline., Conclusion: Postmenopausal women undergoing chemotherapy for early breast cancer experienced significant BMD deterioration in weight-bearing bone, which was further reduced 6 months after chemotherapy., (© 2024. The Japanese Society Bone and Mineral Research.)
- Published
- 2024
- Full Text
- View/download PDF
23. Generation of human hepatobiliary organoids with a functional bile duct from chemically induced liver progenitor cells.
- Author
-
Li P, Miyamoto D, Fukumoto M, Kawaguchi Y, Yamashita M, Tetsuo H, Adachi T, Hidaka M, Hara T, Soyama A, Matsushima H, Imamura H, Kanetaka K, Gu W, and Eguchi S
- Subjects
- Humans, Hepatocytes metabolism, Hepatocytes drug effects, Hepatocytes cytology, Pyrimidines pharmacology, Amides pharmacology, Cell Differentiation drug effects, Pyrazoles, Thiosemicarbazones, Organoids metabolism, Organoids drug effects, Bile Ducts metabolism, Stem Cells metabolism, Stem Cells drug effects, Stem Cells cytology, Pyridines pharmacology, Liver drug effects, Liver metabolism
- Abstract
Background: Liver disease imposes a significant medical burden that persists due to a shortage of liver donors and an incomplete understanding of liver disease progression. Hepatobiliary organoids (HBOs) could provide an in vitro mini-organ model to increase the understanding of the liver and may benefit the development of regenerative medicine., Methods: In this study, we aimed to establish HBOs with bile duct (BD) structures and mature hepatocytes (MHs) using human chemically induced liver progenitor cells (hCLiPs). hCLiPs were induced in mature cryo-hepatocytes using a small-molecule cocktail of TGF-β inhibitor (A-83-01, A), GSK3 inhibitor (CHIR99021, C), and 10% FBS (FAC). HBOs were then formed by seeding hCLiPs into ultralow attachment plates and culturing them with a combination of small molecules of Rock-inhibitor (Y-27632) and AC (YAC)., Results: These HBOs exhibited bile canaliculi of MHs connected to BD structures, mimicking bile secretion and transportation functions of the liver. The organoids showed gene expression patterns consistent with both MHs and BD structures, and functional assays confirmed their ability to transport the bile analogs of rhodamine-123 and CLF. Functional patient-specific HBOs were also successfully created from hCLiPs sourced from cirrhotic liver tissues., Conclusions: This study demonstrated the potential of human HBOs as an efficient model for studying hepatobiliary diseases, drug discovery, and personalized medicine., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
24. Long-term prognosis and DNA damage status after oral mucosal epithelial cell sheet transplantation following esophageal endoscopic submucosal dissection for squamous cell carcinoma: A case series.
- Author
-
Maruya Y, Akazawa Y, Norimatsu K, Sailaubekova Y, Zhumagazhiyeva N, Kobayashi S, Higashi M, Hashiguchi K, Yamaguchi N, Nakashima M, Nakao K, Kanetaka K, and Eguchi S
- Abstract
Autologous oral mucosal epithelial cell sheet (AOMECS) transplantation has recently been applied in human patients to prevent postprocedural stenosis following endoscopic submucosal dissection (ESD) for esophageal squamous cell carcinoma. However, the long-term safety of AOMECS transplantation remains unclear. We evaluated the long-term outcomes of 10 patients who participated in a clinical trial of AOMECS transplantation after esophageal ESD. Additionally, we assessed the local DNA damage response in the esophageal epithelium using p53 binding protein 1 (53BP1) immunofluorescence in post-AOMECS biopsy specimens. The median follow-up period was 118.5 months (range: 46-130 months). Two patients developed primary esophageal cancer near the AOMECS site and successfully underwent additional ESD. One patient developed lymph node metastasis and underwent chemotherapy. None of the patients died from the original disease, although one patient died from unrelated causes. The rate of abnormal 53BP1 nuclear foci, indicative of increased genome instability, increased with the progression of neoplasia in patients post AOMECS. Our case series suggests that AOMECS transplantation provides an acceptable long-term prognosis and 53BP1 foci may serve as a useful marker for assessing DNA instability in the post-AOMECS esophageal epithelium., Competing Interests: The other authors declare no conflicts of interest., (© 2024 The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
25. 18 F-fluorodeoxyglucose positron emission tomography/computed tomography parameters are associated with histological outcomes in superficial esophageal squamous cell carcinoma.
- Author
-
Tanaka H, Hashiguchi K, Tabuchi M, Nessipkhan A, Akashi T, Shiota J, Kitayama M, Matsushima K, Yamaguchi N, Arai J, Kanetaka K, Nakashima M, Kudo T, Nakao K, and Akazawa Y
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Retrospective Studies, Prognosis, Aged, 80 and over, Lymphatic Metastasis diagnostic imaging, Radiopharmaceuticals, Neoplasm Invasiveness, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography methods, Esophageal Squamous Cell Carcinoma diagnostic imaging, Esophageal Squamous Cell Carcinoma pathology, Esophageal Neoplasms pathology, Esophageal Neoplasms diagnostic imaging
- Abstract
Endoscopic submucosal dissection is a standard treatment for early esophageal squamous cell carcinoma. However, submucosal or lymphovascular invasion increases the risk of lymph node metastasis. Although
18 F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) parameters are associated with prognosis in patients with advanced esophageal squamous cell carcinoma, the utility of FDG PET/CT in diagnosing superficial esophageal carcinoma remains unclear. This study aimed to investigate the association between FDG PET/CT parameters and histopathological findings in superficial esophageal carcinoma. Fifty-three patients with superficial esophageal cancer who underwent FDG PET/CT scans before undergoing interventions were retrospectively analyzed. The maximal standardized uptake value (SUVmax ), metabolic tumor volume, and total lesion glycolysis were significantly higher in the cases with submucosal invasion (T1b) compared with those confined to the muscularis mucosa (T1a). In contrast, classification of intrapapillary capillary loops patterns with magnifying endoscopy did not yield statistical differences between T1a and T1b. Multivariable analysis revealed that SUVmax was the only independent predictor of submucosal and lymphovascular invasion. This study demonstrated that SUVmax may be useful in predicting submucosal and lymphovascular invasion. Thus, the value of SUVmax may guide clinical decision-making in superficial esophageal squamous cell carcinoma., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
26. Minimally invasive pancreaticoduodenectomy for circumportal pancreas: literature review and report of two type IIIA cases.
- Author
-
Imamura H, Adachi T, Yamashita M, Kinoshita A, Hamada T, Matsushima H, Hara T, Soyama A, Kobayashi K, Kanetaka K, and Eguchi S
- Abstract
Background: Circumportal pancreas is a rare morphological variant with clinical significance due to the high risk of postoperative pancreatic fistula in patients undergoing pancreaticoduodenectomy. Type IIIA (suprasplenic anteportal) is the most common type of circumportal pancreas. We present two cases of type IIIA treated with minimally invasive pancreaticoduodenectomy, and review the literature on patients with circumportal pancreas who underwent pancreatic surgery., Case Presentation: Case 1: Laparoscopic Pancreaticoduodenectomy for Non-functioning Pancreatic Neuroendocrine Neoplasm with Circumportal Pancreas. A 69-year-old female with no prior medical history presented with a pancreatic head mass detected during routine ultrasound. CT revealed a 20 mm hypervascular tumor in pancreas head and a suprasplenic circumportal pancreas with an anteportal duct. The main pancreatic duct (MPD) was not in the parenchyma on the dorsal side of the portal vein (PV). Laparoscopic pancreaticoduodenectomy was performed. The anteportal side was resected with an ultrasonic device, and the retroportal side with a mesh-reinforced stapler. Pancreaticojejunostomy was performed without complications. Case 2: Robot-assisted Pancreaticoduodenectomy for Pancreatic Head Cancer and Non-functioning Pancreatic Neuroendocrine Neoplasm in the pancreatic tail with Circumportal Pancreas. A 72-year-old male with no prior medical history presented with a dilated main pancreatic duct on ultrasound. Diagnosed with pancreatic head cancer (Stage IIA), he underwent neoadjuvant chemotherapy. Contrast-enhanced CT revealed pancreatic cancer in the head and a tumor in the tail with unknown pathology. Robot-assisted pancreaticoduodenectomy was performed, and pancreatectomy on the left side of the tail tumor was planned. Intraoperative findings revealed a circumportal pancreas with the MPD not running through the dorsal parenchyma. After resected the parenchyma on the left side of the tail tumor, parenchyma on the dorsal side of the PV was dissected using SynchroSeal®. Pancreaticojejunostomy was performed without complications. The postoperative course was uneventful., Conclusions: The optimal location and method of pancreatic resection should be selected according to the type of circumportal pancreas and the location of the lesion to be resected to minimize the risk of pancreatic fistula. Minimally invasive surgery for circumportal pancreas remains challenging even for surgical teams with sufficient experience and skills, and careful consideration are necessary for its application., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
27. How to perform Japanese D3 dissection for transverse colon cancer: a cranial approach to mesenterization of the transverse mesocolon - a video vignette.
- Author
-
Adachi T, Inoue Y, Okada S, Miyoshi T, Kanetaka K, and Eguchi S
- Subjects
- Humans, Colectomy methods, Lymph Node Excision methods, Mesentery surgery, Colon, Transverse surgery, Colonic Neoplasms surgery, Mesocolon surgery
- Published
- 2024
- Full Text
- View/download PDF
28. DCLK1 Expression and its Functional Significance in Intrahepatic Cholangiocarcinoma and Bil-IN Stage.
- Author
-
Fukushima NM, Adachi T, Tanaka T, Matsushima H, Imamura H, Hara T, Soyama A, Hidaka M, Kanetaka K, and Eguchi S
- Subjects
- Humans, Cell Line, Tumor, Cell Movement genetics, Gene Expression Regulation, Neoplastic, Neoplasm Staging, Male, Cell Proliferation, Middle Aged, Female, RNA, Small Interfering genetics, Carcinoma in Situ pathology, Carcinoma in Situ genetics, Carcinoma in Situ metabolism, Cholangiocarcinoma genetics, Cholangiocarcinoma pathology, Cholangiocarcinoma metabolism, Doublecortin-Like Kinases, Protein Serine-Threonine Kinases genetics, Protein Serine-Threonine Kinases metabolism, Intracellular Signaling Peptides and Proteins genetics, Intracellular Signaling Peptides and Proteins metabolism, Bile Duct Neoplasms pathology, Bile Duct Neoplasms genetics, Bile Duct Neoplasms metabolism
- Abstract
Background/aim: Although several studies in some neoplasms have reported correlation between the expression levels of Doublecortin-like kinase1(DCLK1) and carcinogenesis, its role in cholangiocarcinoma remains unknown., Materials and Methods: DCLK1 expression in normal epithelium (NE), biliary intraepithelial neoplasia (BilIN)1∼3, and intrahepatic cholangiocarcinoma (ICC) were investigated immuno-histochemically. The molecular effects of DCLK1 were investigated by gene silencing using RNAi [DCLK1-tagrgeting (siDCLK1)]. The human ICC cell lines HuCCT1 and HuH28 were transfected with these siRNAs, and used for assays in the presence or absence of DCLK1 inhibitors., Results: The positive ratio of DCLK1 expression in ICC was higher than that in NE, and equally distributed among BilIN1∼3 (NE: BilIN1: BilIN2: BilIN3: ICC=62%: 91%: 97%: 100%: 95%, p<0.05). In the wound healing assay, the migration of the siDCLK1-treated cells was significantly inhibited compared to the NT-treated cells (p<0.05). In the cell invasion assay, the invasion of the siDCLK1-treated cells was significantly inhibited compared to the NT-treated cells (p<0.05). In the presence of the DCLK1 inhibitor, cell proliferative capacity at 24 hours was decreased in a concentration-dependent manner., Conclusion: DCLK1 was highly expressed in the early stage of ICC carcinogenesis. Human ICC cell growth was suppressed in vitro by siRNA silencing of DCLK1 or after treatment with the DCLK1 inhibitor, indicating DCLK1 may be molecular target for ICC therapy., (Copyright © 2024 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
29. A first-in-human clinical study of laparoscopic autologous myoblast sheet transplantation to prevent delayed perforation after duodenal endoscopic mucosal dissection.
- Author
-
Kanetaka K, Maruya Y, Higashi M, Yamaguchi S, Matsumoto R, Kobayashi S, Hashiguchi K, Oohashi F, Matsumura M, Naka T, Sakai Y, Nakao K, Miyagawa S, and Eguchi S
- Subjects
- Humans, Male, Female, Middle Aged, Duodenum, Aged, Intestinal Mucosa, Endoscopic Mucosal Resection adverse effects, Endoscopic Mucosal Resection methods, Duodenal Neoplasms surgery, Intestinal Perforation etiology, Laparoscopy methods, Laparoscopy adverse effects, Myoblasts transplantation, Transplantation, Autologous methods
- Abstract
Background: The detection rate of superficial non-ampullary duodenal epithelial tumors (SNADETs) has recently been increasing. Large tumors may contain malignant lesions and early therapeutic intervention is recommended. Endoscopic mucosal dissection (ESD) is considered a feasible treatment modality, however, the anatomical and physiological characteristics of the duodenum create a risk of postoperative perforation after ESD., Methods: To explore whether myoblast sheet transplantation could prevent delayed perforation after ESD, a first-in-human (FIH) clinical trial of laparoscopic autologous myoblast sheet transplantation after duodenal ESD was launched. Autologous myoblast sheets fabricated from muscle tissue obtained seven weeks before ESD were transplanted laparoscopically onto the serous side of the ESD. The primary endpoints were the onset of peritonitis due to delayed perforation within three days after surgery and all adverse events during the follow-up period., Results: Three patients with SNADETs ≥ 20 mm in size underwent transplantation of a myoblast sheet onto the serous side of the duodenum after ESD. In case 1, The patient's postoperative course was uneventful. Endoscopy and abdominal computed tomography revealed no signs of delayed perforation. Despite incomplete mucosal closure in case 2, and multiple micro perforations during ESD in case 3, cell sheet transplantation could prevent the postoperative massive perforation after ESD, and endoscopy on day 49 after transplantation revealed no stenosis., Conclusions: This clinical trial showed the safety, efficacy, and procedural operability of this novel regenerative medicine approach involving transplanting an autologous myoblast sheet laparoscopically onto the serosa after ESD in cases with a high risk of delayed perforation. This result indicates the potential application of cell sheet medicine in treating various abdominal organs and conditions with minimal invasiveness in the future., Trial Registration: jRCT, jRCT2073210094. Registered November 8 2021, https://jrct.niph.go.jp/latest-detail/jRCT2073210094 ., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
30. High serum alpha-fetoprotein and positive immunohistochemistry of alpha-fetoprotein are related to poor prognosis of gastric cancer with liver metastasis.
- Author
-
Takayama-Isagawa Y, Kanetaka K, Kobayashi S, Yoneda A, Ito S, and Eguchi S
- Subjects
- Humans, alpha-Fetoproteins metabolism, Immunohistochemistry, Prognosis, Stomach Neoplasms pathology, Liver Neoplasms surgery
- Abstract
Liver metastasis in gastric cancer is incurable. Alpha-fetoprotein-producing gastric cancer has a poor prognosis and is prone to liver metastasis. We investigated the association between preoperative serum alpha-fetoprotein levels, liver metastasis, and expression of primitive enterocyte phenotype markers. We reviewed the medical records of 401 patients with gastric cancer who underwent curative surgical resection and immunohistochemically evaluated the primitive phenotype markers. The preoperative serum alpha-fetoprotein levels were elevated and normal in 8 and 393 patients, respectively. Liver metastasis was more frequent in patients with higher preoperative alpha-fetoprotein levels. The 5-year postoperative recurrence-free survival and overall survival rates were significantly worse in patients with higher preoperative serum alpha-fetoprotein levels. Although alpha-fetoprotein and Glypican3 and Spalt-like transcription factor 4 tended to be stained with high preoperative serum alpha-fetoprotein levels, these markers were also positive in some patients with normal alpha-fetoprotein levels. In summary, patients with gastric cancer and high preoperative serum alpha-fetoprotein levels have a poor prognosis and high incidence of liver metastasis. Alpha-fetoprotein can help detect liver metastasis relating to the primitive enterocyte phenotype., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
31. Novel nerve-sparing robot-assisted radical prostatectomy with endopelvic fascia preservation and long-term outcomes for a single surgeon.
- Author
-
Maruo M, Goto Y, Miyazaki K, Inoue A, Kurokawa K, Enomoto A, Tanaka S, Katsura S, Sugawara S, Fuse M, Chiba K, Imamura Y, Sakamoto S, Nagata M, and Ichikawa T
- Subjects
- Male, Humans, Retrospective Studies, Prostatectomy, Fascia, Robotics, Surgeons
- Abstract
Although novel techniques for avoiding incontinence during robot-assisted radical prostatectomy have been developed, long-term oncological outcomes are unknown. The objective of this study was to determine the long-term oncological outcomes and functional outcomes of novel nerve-sparing robot-assisted radical prostatectomy with endopelvic fascia preservation for a single surgeon. Data from 100 patients who underwent structure-preserving prostatectomies performed by a single surgeon were retrospectively analyzed. The median console time was 123 min. Bilateral nerve-sparing was performed in 43% of patients underwent, and 57% underwent unilateral nerve-sparing surgery. Most patients (96%) reached complete pad-zero urinary continence by one year after surgery. Satisfactory erectile function was achieved in 97% of patients who underwent bilateral nerve-sparing surgery, and 80% of patients who underwent unilateral nerve-sparing surgery. The surgical margin was positive for 25% of patients, and the biochemical recurrence-free rate at 5 years was 77%. The cancer-specific survival rate was 100% during the median follow-up period of 4.5 years. Clavien-Dindo grade III complications occurred in 1% of cases. The outcomes for novel nerve-sparing robot-assisted radical prostatectomy with endopelvic fascia preservation were similar to previously reported oncological outcomes, with satisfactory functional outcomes. This operative method may be useful for patients who are eligible for nerve-sparing surgery., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
32. Serum wisteria floribunda agglutinin-positive human Mac-2 binding protein is unsuitable as a diagnostic marker of occult hepatocellular carcinoma in end-stage liver cirrhosis.
- Author
-
Nagakawa K, Hidaka M, Hara T, Matsushima H, Imamura H, Tanaka T, Adachi T, Soyama A, Kanetaka K, and Eguchi S
- Subjects
- Humans, Plant Lectins metabolism, Receptors, N-Acetylglucosamine, Liver Cirrhosis complications, Liver Cirrhosis diagnosis, Liver Cirrhosis pathology, Antigens, Neoplasm metabolism, Biomarkers, Carcinoma, Hepatocellular complications, Carcinoma, Hepatocellular diagnosis, Liver Neoplasms diagnosis, Liver Neoplasms diagnostic imaging
- Abstract
Background and Purpose: Serum glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+-M2BP) is a marker of liver fibrosis and hepatocellular carcinoma (HCC). In this study, we aimed to evaluate the diagnostic ability of WFA+-M2BP for occult HCC, which current diagnostic imaging tests fail to detect., Methods: Patients who underwent hepatectomy for liver transplantation (LT) and whose whole liver could be sliced and subjected to histological examination between 2010 and 2018 were eligible for this study (n = 89). WFA+-M2BP levels were measured in samples collected before the LT. Comparison of the postoperative histological test results with the preoperative imaging data grouped the patients into histologically no group (N), histologically detected group (D), histologically increased group (I), and histologically decreased or same group (DS), and the results were compared with the WFA+-M2BP values. In addition, comparisons were made between each data with and without HCC, including occult HCC, and total tumor diameter., Results: Irrespective of underlying hepatic disease conditions, there were 6 patients in the N group, 10 in the D group, 41 in the I group, and 32 in the DS group. The median of the serum WFA+-M2BP level for each group was as follows: N group, 8.05 (1.25-11.9); D group, 11.025 (1.01-18.21); I group, 9.67 (0.29-17.83); and DS group, 9.56 (0.28-19.44) confidence of interval. We found no significant differences between the pairings. Comparison of underlying hepatic diseases revealed that liver cirrhosis due to hepatitis B and C and non-B and -C liver cirrhosis had no significant differences. AFP levels, on the other hand, had significant relationships in comparison between the presence or absence of histological HCC, in correlation between total tumor diameter, and in the ROC analysis for the diagnosis of HCC including occult HCC., Conclusion: Serum WFA+-M2BP cannot help diagnose occult HCC that is already undetected using imaging tests in decompensated liver cirrhosis patients requiring LT., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2023 Nagakawa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
33. Feasibility of Organ Transportation by a Drone: An Experimental Study Using a Rat Model.
- Author
-
Enjoji T, Soyama A, Fukumoto M, Peilin L, Matsuguma K, Imamura H, Maruya Y, Hara T, Matsushima H, Kugiyama T, Adachi T, Hidaka M, Hamamoto S, Takashima S, Maeda T, Kanetaka K, and Eguchi S
- Subjects
- Rats, Animals, Feasibility Studies, Liver pathology, Japan, Alanine Transaminase, Organ Preservation, Unmanned Aerial Devices, Liver Transplantation
- Abstract
Background: Recently, the successful delivery of organs for transplantation using drones was reported. We investigated the influence of transportation by drones on the quality of liver grafts using a rat model., Methods: Livers of 12 rats (8 and 32 weeks old) were divided into 2 groups of six. Livers were split into 2 parts and allocated to the drone or control groups (both n = 12). The drone experiment was conducted between islands in Nagasaki Prefecture, Japan. The distance between the islands was 12 km. Livers of the drone group were transported by a multicopter at a speed of 30 km-40 km/h over 60 m above sea level. Transported liver quality was analyzed by histology, and biochemistry data were compared between groups., Results: Cold ischemia time did not differ between groups (902 min and 909 min, respectively). There were no differences in macroscopic findings regarding coloration and damage between groups. Aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) in preservation fluid were graft weight-corrected and compared, and no significant differences were found between groups: AST/g (4.61 vs 4.81 IU/L), ALT/g (2.78 vs 2.92 IU/L), and ALP/g (39.1 vs 37.0 IU/L). Immunochemical staining showed no significant difference between groups for terminal deoxynucleotidyl transferase dUTP nick and labeling staining (141 vs 113 cells), CD163 (818 vs 870 cells), and TNF-α (1.25 vs 1.41 scores)., Conclusions: The simulation experiment of organ transport for transplantation by drones was successfully conducted. There were no differences in the quality of livers transported by drones or other means. Further studies including large-animal experiments could lead to future clinical applications., Competing Interests: Declaration of Competing Interest All the authors declare no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
34. Total anterior pelvic exenteration with clarification of transanal anatomical landmarks - a video vignette.
- Author
-
Adachi T, Inoue Y, Okada S, Adachi T, Kanetaka K, and Eguchi S
- Subjects
- Humans, Pelvic Exenteration, Rectal Neoplasms surgery
- Published
- 2023
- Full Text
- View/download PDF
35. Ileal Perforation Caused by Metastasis of Breast Carcinoma.
- Author
-
Kagawa D, Kotani M, Miyaguni T, Chibana T, Uezu I, Chinen Y, Maeshiro K, Ono R, Nagahama M, Kinjo I, Tomori H, Miyazato H, Arakaki K, and Hokama A
- Abstract
Competing Interests: CONFLICT OF INTEREST STATEMENT: None declared.
- Published
- 2023
- Full Text
- View/download PDF
36. EFFICACY AND SAFETY OF A DEXAMETHASONE-BASED MOUTHWASH TO PREVENT CHEMOTHERAPY-INDUCED STOMATITIS IN WOMEN WITH BREAST CANCER: A MULTICENTRE, OPEN-LABEL, RANDOMISED PHASE 2 STUDY.
- Author
-
Kuba S, Maeda S, Shibata K, Soutome S, Yamanouchi K, Matsumoto M, Tanaka A, Morita M, Hatachi T, Otsubo R, Yano H, Kawashita Y, Sato S, Taniguchi H, Kanetaka K, Umeda M, Nagayasu T, and Eguchi S
- Subjects
- Humans, Female, Mouthwashes therapeutic use, Cyclophosphamide adverse effects, Dexamethasone therapeutic use, Breast Neoplasms drug therapy, Stomatitis chemically induced, Stomatitis prevention & control, Antineoplastic Agents adverse effects
- Abstract
Purpose: No standard approach other than oral care is available for preventing chemotherapy-induced stomatitis in patients with breast cancer. In this randomized, controlled phase 2 trial, we aimed to assess the efficacy and safety of a dexamethasone-based mouthwash in preventing chemotherapy-induced stomatitis in patients with early breast cancer., Basic Procedures: Patients with breast cancer scheduled for epirubicin and cyclophosphamide (EC) or docetaxel and cyclophosphamide (TC) therapy were selected and allocated in a 1:1 ratio to the intervention and control groups. The intervention group received chemotherapy, oral care, and a dexamethasone-based mouthwash, whereas the control group received chemotherapy and oral care. The primary endpoint was the incidence of stomatitis. This was a phase 2 study, and the significance level for the analysis of the primary endpoint was set a priori at 0.2., Main Findings: Data pertaining to 58 patients in the control group and 59 patients in the intervention group were analyzed. Stomatitis incidence was 55% and 38% in the control and intervention groups, respectively (risk ratio, 0.68; 80% confidence interval, 0.52-0.88; P = .052). Stomatitis severity was lower in the intervention group than in the control group (P = .03). The proportion of patients who adhered to the mouthwash regimen was 87% (interquartile range, 67.8%-95.3%). No severe oral infections were observed., Principal Conclusions: The dexamethasone-based mouthwash safely reduced stomatitis incidence and severity in patients receiving chemotherapy for early breast cancer. Phase 3 clinical trials are warranted for validating our results., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
37. Three-dimensional human bile duct formation from chemically induced human liver progenitor cells.
- Author
-
Li P, Miyamoto D, Huang Y, Adachi T, Hidaka M, Hara T, Soyama A, Matsushima H, Imamura H, Kanetaka K, Gu W, and Eguchi S
- Abstract
Background: The intrahepatic bile ducts (BDs) play an important role in the modification and transport of bile, and the integration between the BD and hepatocytes is the basis of the liver function. However, the lack of a source of cholangiocytes limits in vitro research. The aim of the present study was to establish three-dimensional BDs combined with human mature hepatocytes (hMHs) in vitro using chemically induced human liver progenitor cells (hCLiPs) derived from hMHs. Methods: In this study, we formed functional BDs from hCLiPs using hepatocyte growth factor and extracellular matrix. BDs expressed the typical biliary markers CK-7, GGT1, CFTR and EpCAM and were able to transport the bile-like substance rhodamine 123 into the lumen. The established three-dimensional BDs were cocultured with hMHs. These cells were able to bind to the BDs, and the bile acid analog CLF was transported from the culture medium through the hMHs and accumulated in the lumen of the BDs. The BDs generated from the hCLiPs showed a BD function and a physiological system (e.g., the transport of bile within the liver) when they were connected to the hMHs. Conclusion: We present a novel in vitro three-dimensional BD combined with hMHs for study, drug screening and the therapeutic modulation of the cholangiocyte function., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Li, Miyamoto, Huang, Adachi, Hidaka, Hara, Soyama, Matsushima, Imamura, Kanetaka, Gu and Eguchi.)
- Published
- 2023
- Full Text
- View/download PDF
38. Feasibility of single-port laparoscopic partial adrenalectomy with selective adrenal venous sampling and high-resolution ultrasound for unilateral aldosterone-producing adenomas.
- Author
-
Goto Y, Kitamoto T, Tanaka S, Maruo M, Sugawara S, Chiba K, Miyazaki K, Inoue A, Nakai K, Tsurutani Y, Saito J, Omura M, Nishikawa T, Ichikawa T, and Nagata M
- Subjects
- Humans, Adrenalectomy methods, Aldosterone, Retrospective Studies, Feasibility Studies, Hyperaldosteronism diagnosis, Hyperaldosteronism etiology, Hyperaldosteronism surgery, Adrenocortical Adenoma diagnostic imaging, Adrenocortical Adenoma surgery, Adrenocortical Adenoma complications, Laparoscopy adverse effects, Adenoma diagnostic imaging, Adenoma surgery, Adenoma complications, Adrenal Gland Neoplasms diagnostic imaging, Adrenal Gland Neoplasms surgery, Adrenal Gland Neoplasms complications
- Abstract
Background: The surgical and endocrinological outcomes of single-port laparoscopic partial adrenalectomy for patients with aldosterone-producing adenomas are unknown. Precise diagnosis of intra-adrenal aldosterone activity and a precise surgical procedure may improve outcomes. In this study, we aimed to determine the surgical and endocrinological outcomes of single-port laparoscopic partial adrenalectomy with preoperative segmental selective adrenal venous sampling and intraoperative high-resolution laparoscopic ultrasound in patients with unilateral aldosterone-producing adenomas. We identified 53 patients with partial adrenalectomy and 29 patients with laparoscopic total adrenalectomy. Single-port surgery was performed for 37 and 19 patients, respectively., Methods: A single-center, retrospective cohort study. All patients with unilateral aldosterone-producing adenomas diagnosed by selective adrenal venous sampling and treated surgically between January 2012 and February 2015 were included. Follow-up with biochemical and clinical assessments was set at 1 year after surgery for short-term outcomes and was performed every 3 months after surgery., Results: We identified 53 patients with partial adrenalectomy and 29 patients with laparoscopic total adrenalectomy. Single-port surgery was performed for 37 and 19 patients, respectively. Single-port surgery was associated with shorter operative and laparoscopic times (odds ratio, 0.14; 95% confidence interval, 0.039-0.49; P = .002 and odds ratio, 0.13; 95% confidence interval, 0.032-0.57; P = .006, respectively). All single-port and multi-port partial adrenalectomy cases showed complete short-term (median 1 year) biochemical success, and 92.9% (26 of 28 patients) who underwent single-port partial adrenalectomy and 100% (13 of 13 patients) who underwent multi-port partial adrenalectomy showed complete long-term (median 5.5 years) biochemical success. No complications were observed with single-port adrenalectomy., Conclusion: Single-port partial adrenalectomy is feasible after selective adrenal venous sampling for unilateral aldosterone-producing adenomas, with shorter operative and laparoscopic times and a high rate of complete biochemical success., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
39. Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era.
- Author
-
Goto Y, Utsumi T, Maruo M, Kurozumi A, Noro T, Tanaka S, Sugawara S, Chiba K, Miyazaki K, Inoue A, Komaru A, Fukasawa S, Imamura Y, Sakamoto S, Nakatsu H, Suzuki H, Ichikawa T, and Nagata M
- Subjects
- Male, Humans, Nomograms, Prostate-Specific Antigen, Retrospective Studies, Lymphatic Metastasis pathology, Lymph Node Excision, Lymph Nodes surgery, Lymph Nodes pathology, Prostatectomy, Robotics, Robotic Surgical Procedures, Prostatic Neoplasms surgery, Prostatic Neoplasms pathology
- Abstract
Objectives: To determine candidates for extended pelvic lymph node dissection using a novel nomogram to assess the risk of lymph node invasion in Japanese prostate cancer patients in the robotic era., Methods: A total of 538 patients who underwent robot-assisted radical prostatectomy with extended pelvic lymph node dissection in three hospitals were retrospectively analyzed. Medical records were reviewed uniformly and the following data collected: prostate-specific antigen, age, clinical T stage, primary and secondary Gleason score at prostate biopsy, and percentage of positive core numbers. Finally, data from 434 patients were used for developing the nomogram and data from 104 patients were used for external validation., Results: Lymph node invasion was detected in 47 (11%) and 16 (15%) patients in the development and validation set, respectively. Based on multivariate analysis, prostate-specific antigen, clinical T stage ≥3, primary Gleason score, grade group 5, and percentage of positive cores were selected as variables to incorporate into the nomogram. The area under the curve values were 0.781 for the internal and 0.908 for the external validation, respectively., Conclusions: The present nomogram can help urologists identify candidates for extended pelvic lymph node dissection concomitant with robot-assisted radical prostatectomy among patients with prostate cancer., (© 2023 The Japanese Urological Association.)
- Published
- 2023
- Full Text
- View/download PDF
40. A case of tracheotomy using the Ex Utero Intrapartum Treatment (EXIT) procedure in cooperation with multiple professions.
- Author
-
Asai Y, Kato H, Horibe K, Hiei Y, and Tateya I
- Abstract
In this study, we report a case of tracheotomy using the ex utero intrapartum treatment (EXIT) procedure in a fetus that was pointed out as having bilateral giant cervical cysts at prenatal diagnosis and whose postnatal airway occlusion was predicted. The subject was a female aged 35. She was diagnosed with polyhydramnios at 28 weeks of pregnancy. The fetus was found to have a giant cervical cyst before she was referred to the department of obstetrics and gynecology of our hospital. On the second day of 37 weeks of pregnancy, oral tracheal intubation was attempted on the fetus using the EXIT procedure after the caesarean operation, but intubation was difficult resulting in a tracheotomy. The oxygenation of the fetus during the operation was maintained well without any postoperative complication. Postnatal fetal airway occlusion is a critical incident which may lead to the death of a fetus. It was assumed, however, that the airway management under the same procedure was completed by the preoperative detailed simulation with the staff of the departments of anesthesiology, obstetrics and gynecology and pediatrics as well as the operating room personnel., Competing Interests: There is no conflict-of-interest to be disclosed concerning this article.
- Published
- 2023
- Full Text
- View/download PDF
41. Stress exacerbates pancreatic cancer both directly and indirectly by creating an immunosuppressive environment.
- Author
-
Ikeda T, Adachi T, Tanaka T, Miyamoto D, Imamura H, Matsushima H, Yamamoto K, Hidaka M, Kanetaka K, and Eguchi S
- Subjects
- Animals, Mice, Pancreatic Neoplasms, Pancreatic Neoplasms metabolism, Myeloid-Derived Suppressor Cells metabolism
- Abstract
Background/purpose: Sympathetic nerve stimulation by stress exacerbates various solid tumors, including pancreatic cancer (PCa). The relationship between cancer and immunity has been suggested; however, there is limited information about the effects of nerve stimulation on immunity and cancer. We aimed to investigate the involvement of sympathetic nerve stimulation in immune cells and its effects on PCa using a restraint stress mouse model., Methods: In the in vitro experiment, the mouse-derived PCa cell line (LTPA) was cultured in a noradrenalin-supplemented medium. In the in vivo experiment, mice were divided into non-stress and stress groups., Results: LTPA proliferated significantly more when cultured in a noradrenalin-supplemented medium than in a normal medium. Flow cytometry analysis of blood immune cells revealed a significant decrease in B cells, T cells, and macrophages and a significant increase in myeloid-derived suppressor cells (MDSCs) in the stress group. Furthermore, a significant increase in blood noradrenaline levels was observed in the stress group (p < .01). In the PCa mice model, immune cells in the blood showed a similar trend, and the stress group had a poor prognosis. Furthermore, immunostaining at the tumor site showed that there was a lower number of B and T cells in the stress group. In addition, MDSCs were present at the tumor margins., Conclusion: These results suggest that sympathetic nerve stimulation is not only directly involved in PCa growth but also exacerbates PCa by creating an immunosuppressive environment in the blood and tumor tissue., (© 2022 Japanese Society of Hepato-Biliary-Pancreatic Surgery.)
- Published
- 2023
- Full Text
- View/download PDF
42. Association of quantitative analysis of intratumoral reduced E-cadherin expression with lymph node metastasis and prognosis in patients with breast cancer.
- Author
-
Meng X, Morita M, Kuba S, Hayashi H, Otsubo R, Matsumoto M, Yamanouchi K, Kobayashi K, Soyama A, Hidaka M, Kanetaka K, Nagayasu T, and Eguchi S
- Subjects
- Female, Humans, Biomarkers, Tumor analysis, Cadherins metabolism, Immunohistochemistry, Lymphatic Metastasis, Prognosis, Breast Neoplasms pathology
- Abstract
Loss of E-cadherin expression is a poor prognostic factor in patients with breast cancer. Breast cancer cells co-cultured with adipocytes reportedly promote E-cadherin attenuation and tumor progression. The current study aimed to investigate the association of reduced E-cadherin expression with adipose tissue invasion (ATI) and prognosis in breast cancer. Surgical specimens were collected from 188 women with invasive ductal carcinoma of the breast who had undergone surgery without neoadjuvant treatment. We compared E-cadherin expression in ATI and invasive front (IF) using immunohistochemistry with ImageJ. Reduced E-cadherin expression was detected not only in the ATI area but also in the IF, and the degree of reduced E-cadherin expression was positively correlated with both areas. In patients with lymph node metastasis compared to those without, E-cadherin expression was reduced and this reduction was associated with poor recurrence-free survival. We concluded that E-cadherin expression is reduced not only at the ATI area but also at the IF of the tumor. Reduced E-cadherin expression is a clear prognostic factor for breast cancer. Hence, future research is warranted for establishing an objective and quantitative E-cadherin staining assay that will allow clinical use of E-cadherin as a prognostic factor., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
43. Association between Genetic Variation in the TAS2R38 Bitter Taste Receptor and Propylthiouracil Bitter Taste Thresholds among Adults Living in Japan Using the Modified 2AFC Procedure with the Quest Method.
- Author
-
Aoki K, Mori K, Iijima S, Sakon M, Matsuura N, Kobayashi T, Takanashi M, Yoshimura T, Mori N, and Katayama T
- Subjects
- Adult, Humans, Propylthiouracil, Japan, Bayes Theorem, Receptors, G-Protein-Coupled genetics, Taste Perception genetics, Genotype, Polymorphism, Genetic, Genetic Variation, Taste genetics, Taste Threshold genetics
- Abstract
Individual taste sensitivity influences food preferences, nutritional control, and health, and differs greatly between individuals. The purpose of this study was to establish a method of measuring and quantifying an individual's taste sensitivity and to evaluate the relationship between taste variation and genetic polymorphisms in humans using agonist specificities of the bitter taste receptor gene, TAS2R38 , with the bitter compound 6-n-propylthiouracil (PROP). We precisely detected the threshold of PROP bitter perception by conducting the modified two-alternative forced-choice (2AFC) procedure with the Bayesian staircase procedure of the QUEST method and examined genetic variation in TAS2R38 in a Japanese population. There were significant differences in PROP threshold between the three TAS2R38 genotype pairs for 79 subjects: PAV/PAV vs AVI/AVI, p < 0.001; PAV/AVI vs AVI/AVI, p < 0.001; and PAV/PAV vs PAV/AVI, p < 0.01. Our results quantified individual bitter perception as QUEST threshold values: the PROP bitter perception of individuals with the PAV/PAV or PAV/AVI genotypes was tens to fifty times more sensitive than that of an individual with the AVI/AVI genotype. Our analyses provide a basic model for the accurate estimation of taste thresholds using the modified 2AFC with the QUEST approach.
- Published
- 2023
- Full Text
- View/download PDF
44. Therapeutic effect and mechanism of Daikenchuto in a model of methotrexate-induced acute small intestinal mucositis.
- Author
-
Li P, Inoue Y, Miyamoto D, Adachi T, Okada S, Adachi T, Soyama A, Hidaka M, Kanetaka K, Ito S, Sadatomi D, Mogami S, Fujitsuka N, Gu W, and Eguchi S
- Subjects
- Rats, Animals, Methotrexate toxicity, Intestinal Mucosa metabolism, Mucositis chemically induced, Mucositis drug therapy, Mucositis pathology, Panax, Enteritis pathology
- Abstract
Background: Daikenchuto (DKT) has positive therapeutic effects on improving various gastrointestinal disorders. The present study investigated whether or not DKT has a potential therapeutic effect on chemotherapy-induced acute small intestinal mucositis (CIM) in a rat model., Methods: Intraperitoneal injection of 10 mg/kg methotrexate (MTX) every 3 days for a total of 3 doses was used for induction of CIM in a rat model. The MTX and DKT-MTX groups were injected with MTX as above from the first day, and the DKT-MTX and DKT groups were administered 2.7% DKT via the diet at the same time. The rats were euthanized on day 15., Results: The DKT-MTX group showed an improvement in the body weight and conditions of gastrointestinal disorders as well as increased levels of diamine oxidase in plasma and in the small intestinal villi. The pathology results showed that small intestinal mucosal injury in the DKT-MTX group was less severe than that in the MTX group. Immunohistochemistry for myeloperoxidase and malondialdehyde and quantitative real-time polymerase chain reaction (RT-qPCR) for TGF-β1 and HIF-1α showed that DKT attenuated peroxidative damage. The crypts in the DKT-MTX group contained more Ki-67-positive cells than MTX group. The zonula occluden-1 and claudin-3 results showed that DKT promoted repair of the mucosal barrier. RT-qPCR for the amino acid transporters EAAT3 and BO+AT also confirmed that DKT promoted mucosal repair and thus promoted nutrient absorption., Conclusion: DKT protected against MTX-induced CIM in a rat model by reducing inflammation, stimulating cell proliferation, and stabilizing the mucosal barrier., Competing Interests: The authors of Peilin Li, Yusuke Inoue, Daisuke Miyamoto, Toshiyuki Adachi, Satomi Okada, Tomohiko Adachi, Akihiko Soyama, Masaaki Hidaka, Kengo Kanetaka, Shinichiro Ito and Susumu Eguchi received a research grant from Tsumura & Co. Daichi Sadatomi, Naoki Fujitsuka and Sachiko Mogami are employed by Tsumura & Co. All authors who took part in this study promised to avoid conflicts of interest (even superficial ones) with the company and the research process, and the results conformed to the research specification. All authors undertook to ensure that the personal conduct of all participants was in accordance with the guidelines and to report appropriately when there is a potential for any actual or potential conflict. All the other authors declared no competing interests. The funder provided support in the form of salaries for Daichi Sadatomi, Naoki Fujitsuka and Sachiko Mogami, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section., (Copyright: © 2023 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
45. Double vision approach applied by two teams for retrosternal gastric conduit for gastric tube cancer.
- Author
-
Machino R, Kobayashi S, Tagawa T, Taniguchi K, Kanetaka K, Eguchi S, and Nagayasu T
- Abstract
Gastric tube cancer is classically treated with resection through a midline sternal incision. However, because of its invasiveness and limited reconstructive potential, transdiaphragmatic laparoscopic or thoracoscopic dissection of the gastric tube has been investigated. As resection from only the abdominal or thoracic cavity is difficult, we performed surgery with a thoracic surgeon approaching from the thoracic cavity and an abdominal surgeon simultaneously approaching from the cervical and abdominal regions. The gastric tube may be tightly adhered to the back of the sternum, cervicothoracic transition or thoracoabdominal transition. Dissection can be safely performed by operating from two directions simultaneously, the neck and chest or chest and abdomen, to successfully withdraw the gastric tube from the abdominal cavity. We performed this surgery in four cases. This collaborative operation provided a good surgical view and allowed for safe dissection of the gastric tube without requiring sternotomy., (Published by Oxford University Press and JSCR Publishing Ltd. © The Author(s) 2023.)
- Published
- 2023
- Full Text
- View/download PDF
46. Endoscopic mucosal ischemic index for predicting anastomotic complications after esophagectomy: a prospective cohort study.
- Author
-
Kobayashi S, Kanetaka K, Yoneda A, Yamaguchi N, Kobayashi K, Nagata Y, Maruya Y, Yamaguchi S, Hidaka M, and Eguchi S
- Subjects
- Humans, Anastomosis, Surgical adverse effects, Anastomotic Leak diagnosis, Anastomotic Leak epidemiology, Anastomotic Leak etiology, Constriction, Pathologic surgery, Ischemia etiology, Ischemia surgery, Mucous Membrane pathology, Mucous Membrane surgery, Postoperative Complications diagnosis, Postoperative Complications epidemiology, Postoperative Complications etiology, Prospective Studies, Retrospective Studies, Esophageal Neoplasms surgery, Esophagectomy adverse effects
- Abstract
Background: Postoperative complications related to gastric conduit reconstruction are still common issues after McKeown esophagectomy. A novel endoscopic mucosal ischemic index is desired to predict anastomotic complications after McKeown esophagectomy., Aims and Methods: The purpose of this study was to prospectively evaluate the safety and efficacy of endoscopic examinations of the anastomotic region in the acute period after esophagectomy. Endoscopic examinations were performed on postoperative days (PODs) 1 and 8. The severity of ischemia was prospectively validated according to the endoscopic mucosal ischemic index (EMII)., Results: A total of 58 patients were included after evaluating the safety and feasibility of the endoscopic examination on POD 1 in 10 patients. Anastomotic leakage occurred in 6 patients. Stricture occurred in 13 patients. A greater than 67% circumference and lesion length greater than 20 mm of anastomotic ischemic area (AIA) on POD 1 were associated with developing anastomotic leakage after esophagectomy (OR: 14.5; 95% CI: 1.8-306.5; P = 0.03, OR: 19.4; 95% CI: 1.7-536.8; P = 0.03). More than 67% circumferential ischemic mucosa and ischemic mucosal lengths greater than 20 mm of AIA on POD 1 were associated with developing anastomotic strictures after esophagectomy (OR: 6.4; 95% CI: 1.4-31.7; P = 0.02, OR: 5.9; 95% CI: 1.2-33.1; P = 0.03). Patients with either more than 67% circumferential ischemic mucosa or ischemic mucosal lengths greater than 20 mm of AIA on POD 1 were defined as EMII-positive patients. The sensitivity, specificity, and positive and negative predictive values of EMII positivity on POD 1 for leakage were 100%, 78.8%, 35.3%, and 100%, respectively. The sensitivity, specificity, and positive and negative predictive values of the EMII positivity on POD 1 for strictures were 69.2%, 82.2%, 52.9%, and 90.2%, respectively., Conclusions: The application of an endoscopic classification system to mucosal ischemia after McKeown esophagectomy is both appropriate and satisfactory in predicting anastomotic complications., Trial Registration: Clinical Trial.gov Registry, ID: NCT02937389, Registration date: Oct 17, 2015., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
47. Successful resection of large submucosal tumor in the esophagus: Novel thoracoscopic-endoscopic combined surgery with submucosal tunneling method.
- Author
-
Inomata H, Minami H, Kanetaka K, Shiota J, Tabuchi M, Eguchi S, and Nakao K
- Abstract
Competing Interests: Competing interests The authors declare that they have no conflict of interest.
- Published
- 2023
- Full Text
- View/download PDF
48. Pathologic Complete Response after Chemotherapy with Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma with Tumor Thrombus in the Main Portal Trunk.
- Author
-
Kurisaki K, Soyama A, Hara T, Matsushima H, Imamura H, Tanaka T, Adachi T, Ito S, Kanetaka K, Hidaka M, Okano S, and Eguchi S
- Subjects
- Male, Humans, Bevacizumab therapeutic use, Biomarkers, Tumor, Portal Vein surgery, Carcinoma, Hepatocellular complications, Carcinoma, Hepatocellular drug therapy, Carcinoma, Hepatocellular surgery, Liver Neoplasms complications, Liver Neoplasms drug therapy, Liver Neoplasms pathology, Venous Thrombosis etiology, Venous Thrombosis complications, Thrombosis diagnostic imaging, Thrombosis drug therapy, Thrombosis etiology
- Abstract
We report a case of pathologic complete response after successful treatment for advanced hepatocellular carcinoma (HCC) complicated with portal venous tumor thrombus with atezolizumab and bevacizumab followed by radical resection. The patient was a male in his 60s. During follow-up for chronic hepatitis B, abdominal ultrasonography revealed a huge tumor located in the right lobe of the liver with the portal vein thrombosed by the tumor. The tumor thrombus extended to the proximal side of the left branch of the portal vein. The patient's tumor marker levels were elevated (alpha-phetoprotein, 14,696 ng/mL; PIVKA-II, 2,141 mAU/mL). Liver biopsy revealed poorly differentiated HCC. The lesion was categorized as advanced stage according to the BCLC staging system. As systemic therapy, atezolizumab plus bevacizumab was administered. Imaging showed marked shrinkage of the tumor and portal venous thrombus with a remarkable decrease of tumor marker levels after 2 courses of chemotherapy. After 3 additional courses of chemotherapy, radical resection was considered possible. The patient underwent right hemihepatectomy and portal venous thrombectomy. A pathological examination revealed a complete response. In conclusion, we experienced a case in which advanced HCC was curatively treated with atezolizumab plus bevacizumab, which was administered as systemic therapy with a view to conversion surgery., (© 2023 S. Karger AG, Basel.)
- Published
- 2023
- Full Text
- View/download PDF
49. [Regenerative medicine for the gastrointestinal diseases in Japan and abroad].
- Author
-
Kanetaka K and Eguchi S
- Subjects
- Humans, Japan, Regenerative Medicine, Gastrointestinal Diseases therapy
- Published
- 2023
- Full Text
- View/download PDF
50. Exenatide challenge in oral glucose tolerance test is insufficient for predictions of glucose metabolism and insulin secretion after sleeve gastrectomy (SG) in obese patients with type 2 diabetes: a pilot study to establish a preoperative model to estimate β-cell function following augmented glucagon-like peptide-1 secretion after SG.
- Author
-
Nakamura Y, Horie I, Kanetaka K, Eguchi S, Nakamichi S, Hongo R, Takashima M, Kawakami A, and Abiru N
- Subjects
- Humans, Glucose Tolerance Test, Insulin Secretion, Exenatide, Pilot Projects, Obesity complications, Obesity surgery, Insulin metabolism, Glucose, Gastrectomy methods, Blood Glucose metabolism, Glucagon-Like Peptide 1, Diabetes Mellitus, Type 2 metabolism
- Abstract
The postoperative increase in glucagon-like peptide-1 (GLP-1) is the main factor to improve glucose metabolism following sleeve gastrectomy (SG) in obese patients with type 2 diabetes. We investigated whether the β-cell responsiveness to an injection of exogenous GLP-1 in the preoperative period could determine the postoperative glucose tolerance in 18 patients underwent SG. In the preoperative period, a regular oral glucose tolerance test (OGTT) and an exenatide-challenge during OGTT (Ex-OGTT) were performed to evaluate the β-cell function and its responsiveness to GLP-1. The postoperative glucose tolerance was evaluated by another regular OGTT performed at 3 months after SG. The significant decrease in glucose levels with enhanced secretions of insulin and GLP-1 was observed in OGTT at 3 months after SG. The area under the curve of glucose from 0 to 120 minutes (AUC glucose
0-120 min ) and the insulinogenic index (I.I.) in OGTT at 3 months post-SG were significantly improved compared to those in preoperative period, but comparable with those in Ex-OGTT. AUC glucose0-120 min and I.I. in OGTT at 3 months post-SG were significantly correlated with not only those in Ex-OGTT, but also those in the preoperative regular OGTT. Conversely, the correlations calculated by the Spearman's ρ were stronger in the latter than the former. This exenatide-challenge protocol might be useful to estimate glucose tolerance and insulin secretion after SG, however, it may be insufficient to improve predictability of a patient who is likely to achieve a significant benefit on glucose metabolism from receiving SG.- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.